<DOC>
	<DOCNO>NCT01485718</DOCNO>
	<brief_summary>Glucomannan dietary supplement market weight loss . There research support claim research necessary . This research study conduct determine dietary supplement glucomannan effective weight loss adult great 18 year age overweight . Participants randomize 1:1 manner ( like flip coin ) receive either glucomannan 575 milligram , 2 capsule three time daily placebo , 2 capsule three time daily . The study last 12 week . At start study participant ask question current medication diet/exercise regimen , weight height obtain , give one-month 's supply study supplement . An investigator call participant take supplement 2 week ensure participant tolerate supplement answer question . Throughout study , participant require follow-up investigator office every 4 week ( total 3 follow-up appointment ) . Every 4 week , investigator weigh participant , count leftover capsule previous month , ask adverse effect may experience . At conclusion study , final weight compare baseline weight determine medication effect weight loss .</brief_summary>
	<brief_title>Effect Daily Glucomannan Overweight Patients</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>( 1-6 ) -alpha-glucomannan</mesh_term>
	<criteria>Patients ≥18 year old Overweight ( BMI ≥ 25 kg/m2 ) Pregnant nurse woman Women childbearing age exclude unless form contraception Participation formal informal weight reduction program 1 . Currently enrol another weight loss study 2 . Currently enrol weight loss program 3 . Active attempt lose weight diet and/or exercise within last month 4 . Currently one follow medication know cause weight loss : Alli/Xenical ( orlistat ) AdipexP ( phentermine ) Bontril ( phendimetrazine ) Dexoxyn ( methamphetamine ) Didrex ( benzphetamine ) Tenuate ( diethylpropion ) Meridia ( sibutramine ) Byetta ( exenatide ) Victoza ( liraglutide ) Stimulants Recently ( within last three month ) start medication may cause weight gain A diagnosis heart failure Structural abnormality esophagus gut Previous GI surgery weight reduction Inflammatory bowel irritable bowel disease A life expectancy &lt; 6 month Allergy glucomannan component placebo</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Overweight</keyword>
	<keyword>Weight loss</keyword>
</DOC>